期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

化生性乳腺癌中基底细胞样标志物的表达及意义 被引量：1

Expressions of basal-like markers and their significance in metaplastic breast carcinoma
下载PDF
导出
摘要 目的:探讨化生性乳腺癌(MBC)中基底细胞样标志物的表达及意义。方法:采用HE、免疫组化(EnVision法)和荧光原位杂交(FISH)方法观察7例MBC,并结合文献进行分析。结果:7例化生性乳腺癌中,3例为鳞状细胞癌,1例为腺鳞癌,1例为梭形细胞化生,2例伴软骨或骨化生。7例免疫标志物检测的阳性率:雌激素受体(ER)、孕激素受体(PR)和HER-2均为0%(0/7),细胞角蛋白5/6(CK5/6)为100%(7/7),细胞角蛋白14(CK14)为71.4%(5/7),表皮生长因子受体(EGFR)为85.7%(6/7),P63为71.4%(5/7)。1例行FISH检测未见HER-2基因明显扩增。结论:MBC具有基底细胞样表型。 Objective To study the expressions of basal cell-like markers and their significance in metaplastie breast carcinoma. Methods Seven cases of metaplastic breast carcinoma were studied with HE staining, EnVision immunostaining and fluorescence in situ hybridization （FISH）, and related literatures were reviewed. Results Of these seven cases of metaplastic breast carcinoma, 3 were squamous cell carcinoma, 1 was adenosquamous carcinoma, 1 was carcinoma with spindle cell metaplasia, and 2 were carcinoma with cartilaginous element or osseous element. Immunohistochemically, the positive rates were ER 0%（0/7）, PR 0%（0/7）, HER-2 0%（0/7）, CK5/6 100%（7/7）, CK14 71.4% （5/7）, EGFR 85.7%（6/7）, P63 71.4%（5/7）. FISH test was performed in one case and no apparent amplification of HER-2 gene was seen. Conclusions Metaplastic breast carcinomas has basal cell-like phenotype.
作者 王海 冷冬妮 王建东 周航波 姚育英 石群立 周晓军
机构地区 南京军区南京总医院病理科 解放军第
出处 《诊断学理论与实践》 2009年第6期635-638,共4页 Journal of Diagnostics Concepts & Practice
基金 南京军区南京总医院青年基金课题(Q2008065)
关键词 乳腺 化生性癌 基底细胞样型乳腺癌 基底细胞样标志物 诊断 Breast, metaplastic carcinoma Basal-like breast carcinoma Basal-like marker Diagnosis
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours [J]. Nature, 2000, 406(6797):747-752.
  • 2Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: a critical review [J]. J Clin Oncol, 2008, 26(15): 2568-2581.
  • 3Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma [J]. Clin Cancer Res, 2004, 10(16):5367-5374.
  • 4Rakha EA, Reis-Filho JS, Ellis IO. hnpact of basal-like breast carcinoma determination for a more specific therapy[J]. Pathobiology, 2008, 75(2): 95-103.
  • 5Reis-Filho JS, Milanezi F, Steele D, et al. Metaplastic breast carcinomas are basal-like tumours [J]. Histopathology, 2006,49(1):10-21.
  • 6Kim M J, Ro JY, Ahn SH, et al. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neuoverexpressing phenotypes[J]. Hum Pathol, 2006, 37(9): 1217-1226.
  • 7Kuroda N, Fujishima N, Inoue K, et al. Basal-like carcinoma of the breast: further evidence of the possibility that most metaplastie carcinomas may be actually basal- like carcinomas[J]. Med Mol Morphol, 2008, 41(2): 117- 120.
  • 8Reis-Filho JS, Pinheiro C, Lambros MB, et al. EGFR amplification and lack of activating mutations in metaplastic breast carcinomas [J]. J Pathol, 2006,209(4):445-453.
  • 9Bhargava R, Gerald WL, Li AR, el al. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations [J]. Mod Pathol, 2005, 18(8):1027-1033.
  • 10Gilbert JA, Goetz MP, Reynolds CA, et al. Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy [J]. Mol Cancer Ther, 2008,7 (4):944-951.

同被引文献15

  • 1李新军,魏兵,步宏,张红英,陈卉娇,陈海玲.含有鳞状细胞癌成分的乳腺化生性癌临床病理特征[J].临床与实验病理学杂志,2006,22(5):531-536. 被引量：3
  • 2Tavassoli FA.乳腺及女性生殖器官肿瘤病理学和遗传学[M].程虹等译.北京:人民卫生出版社,2006.312.
  • 3Toumi Z, Bullen C, Tang AC, et al. Metaplastic breastcarcinoma: a case report anl systematic review oi Ule literature [J]. Pathollnt, 2011, 61(10) :582-588.
  • 4Rakha EA, Reis-Filho JS, Ellis IO. Impact of basal-like breast carcinoma determination for a more specific therapy [ J ]. Pathobiology, 2008, 75(2) :95 - 103.
  • 5Park JM, Han BK, Moon WK, et al. Metaplastic carcinoma of the breast : mammographic and sonographic findings [ J ]. J Clin Ultrasound, 2000, 28(4): 179 186.
  • 6Gauehotte G, carcinomas Gauehotte E, Bressenot A, et al. Metaplastic of the breast: a morphological and immunohistochemical study [J]. Ann Pathol, 2011, 31 ( 1 ) : 18 - 27.
  • 7Shui R, Bi R, Cheng Y, et al. Matrix-producing carcinoma of the breast in the Chinese population: a clinicopathological study of 13 cases[J]. Pathol Int, 2011,61(7) :415 -422.
  • 8Kusafuka K, Muramatsu K, Kasami M, et al. Cartilaginous features in matrix-producing carcinoma of the breast: four cases report with histochemical and immunohistochemical analysis of matrix molecules[ J]. Mod Pathol,2008 ,21 (10) :1282 - 1292.
  • 9Milanezi F, Pereira EM, Ferreira FV, et al. CD99/MIC-2 surface protein expression in breast carcinomas [ J ]. Histopathology ,2001 ,39 (6) :578 - 583.
  • 10Gobbi H, Simpson JF, Borowsky A, et al. Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrent [ J ]. Cancer, 1999, 85 ( 10 ) : 2170 -2182.

引证文献1

二级引证文献4

诊断学理论与实践
2009年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部